GENE ONLINE|News &
Opinion
Blog

Novo Nordisk
The GLP-1 Gold Rush: Lilly, Novo and New Rivals Chase a $260 Billion Market
2026-03-04
[Illustrations] Global Blockbuster Drug Landscape Shifts in 2026: Keytruda Defends No. 1, “Diabesity” Rivals Surge, IRA Price Caps Take Effect
2026-01-22
JPM 2026 Recap: Capital Markets Reopen, AI Moves to the Last Mile, Metabolic Stakes Climb
2026-01-15
Global Diabetes Drug Market 2025: Top 10 Players and Industry Outlook
2025-11-12
2024 Top 10 Diabetes Drugs and Promising Type 1 Treatments to Watch
2025-11-05
Novo Nordisk Cracks Down on Unsafe Compounded “Semaglutide” with New Wave of Lawsuits
2025-08-06
A New Contender Rises: China’s Hengrui and Innovent Challenge Zepbound and Wegovy in Global Weight-Loss Drug Race
2025-07-16
Fake Ozempic Floods Market as FDA Warns Patients to Check Authenticity of Prescriptions
2025-04-16
Novo Nordisk Acquires Lexicon’s LX9851 for $1B to Expand Weight Loss Drug Portfolio
2025-04-04
Novo Nordisk Secures Rights to Lexicon’s LX9851, Aiming to Enhance Obesity Treatments
2025-03-29
Novo Nordisk Rejoins British Pharmaceutical Industry Association After Suspension
2025-03-19
Novo Nordisk Introduces Lower-Cost Wegovy via Direct-to-Patient Sales Platform
2025-03-06
Novo Nordisk Announces Price Reduction for Wegovy Weight Loss Drug Amid Growing Demand
2025-03-06
Novo Nordisk Takes on Eli Lilly in Weight Loss Drug Battle with Wegovy Price Cut
2025-03-06
Gensaic Partners with Novo Nordisk in $354M Deal to Advance Precision Therapies for Cardiometabolic Diseases
2025-03-04
1 2 3 4
LATEST
David vs. Goliath: Taiwan’s PGI Wins $23M Settlement in Sequencing Patent Dispute with U.S. PacBio
2026-03-13
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
Dividend Exchange Rate for Q3 2025 Announced by DEC on March 12, 2026
2026-03-12
NewHydrogen Files International Patent Application for ThermoLoop Technology to Enhance Hydrogen Production Efficiency
2026-03-12
BioGene Therapeutics Inc. Appoints Raj S. Pruthi as Director
2026-03-12
Scroll to Top